ATRA - CIK 0001604464
Atara Biotherapeutics, Inc. (ATRA) reported revenue of $120.77M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $120.77M | -6.3% |
| FY 2024 | $128.94M | +1404.0% |
| FY 2023 | $8.57M | -86.5% |
| FY 2022 | $63.57M | - |
Atara Biotherapeutics, Inc. (ATRA) reported revenue of $120.77M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.